Investigation of the in vitro performance difference of drug-Soluplus® and drug-PEG 6000 dispersions when prepared using spray drying or lyophilization
Purpose: To evaluate the physicochemical and in vitro characteristics of solid dispersions using BCS II model drugs with Soluplus® and one of its component homopolymers, PEG 6000. Methods: Nifedipine (NIF) and sulfamethoxazole (SMX) of 99.3% and 99.5% purity, respectively, were selected as BCS II mo...
Saved in:
Main Authors: | Mohammad A. Altamimi (Author), Steven H. Neau (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2017-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Effect of Tween 20, 60, and 80 on Dissolution Behavior of Sprionolactone in Solid Dispersions Prepared by PEG 6000
by: Jafar Akbari, et al.
Published: (2015) -
Amorphicity and Aerosolization of Soluplus-Based Inhalable Spray Dried Powders
by: Bishal Raj Adhikari, et al.
Published: (2022) -
Spray-Dried Amorphous Solid Dispersions of Griseofulvin in HPC/Soluplus/SDS: Elucidating the Multifaceted Impact of SDS as a Minor Component
by: Mahbubur Rahman, et al.
Published: (2020) -
Study of gliclazide solid dispersion systems using PVP K-30 and PEG 6000 by solvent method
by: Febriyenti Febriyenti, et al.
Published: (2019) -
Efficient Improvement of Eugenol Water Solubility by Spray Drying Encapsulation in Soluplus<sup>®</sup> and Lutrol F 127
by: Iskra Z. Koleva, et al.
Published: (2024)